The primary objective ofthe Cancer Prevention (CP) program is to use population science research methods to improve the knowledge base for promoting overall reductions in cancer incidence, mortality and morbidity. The CP program has 21 members from 11 academic departments. This group of investigators accomplishes its goals through effective integration of expertise in Family &Preventive Medicine, Psychiatry, Communication, Computer Science and Engineering, Pediatrics, Psychology, Surgery, Endocrinology, Reproductive Medicine, and Public Health. The program is organized in 3 major scientific themes as follows. Theme 1 is Cancer-Related Policy Research;Theme 2 is Diet, Obesity, and Cancer Risk;Theme 3 is Physical Activity Assessment and Interventions. In 2012, the CP program had $10.2 million of peer reviewed research grant funding (direct costs), including $4.1 million from NCI. Members ofthe CP program published 554 programmatically aligned articles since 2007;24% were the result of intra-programmatic collaborations and 20% were inter-programmatic. Significant scientific accomplishment include: (i) publication of the first report showing that nonsmoking policies have substantially reduced lung cancer rates in California and that this decline resulted from a decrease in the proportion of heavy smokers, (ii) the Women's Healthy Eating and Living (WHEL) study showed that maintenance of a low-fat diet high in vegetables, fruit, and fiber did not reduce recurrence or death in breast cancer survivors, and (iii) authorship of a landmark paper on built environment measures for physical activity. The program was active in 2012 with 1471 new patients in enrolled in intervention trials and 609 participants in observational studies. Proportions of participants by ethnic and racial categories approximate the MCC catchment area for adults aged 50 years and older (i.e., adults at risk of common-incidence cancers). The Cancer Center adds value to the research projects in CP by providing shared resource facilities, consultation on state of the art technologies, pilot project grants, opportunities for collaboration with other MCC programs, and recruitment of investigators.

Public Health Relevance

The primary objective ofthe Cancer Prevention (CP) program is to use population science research methods to improve the knowledge base for promoting overall reductions in cancer incidence, mortality and morbidity. The program focus areas include health behavior policy, studies of diet and obesity, and research in physical activity.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA023100-28
Application #
8695642
Study Section
Subcommittee G - Education (NCI)
Project Start
1996-07-01
Project End
2019-04-30
Budget Start
2014-07-21
Budget End
2015-04-30
Support Year
28
Fiscal Year
2014
Total Cost
$26,399
Indirect Cost
$9,198
Name
University of California San Diego
Department
Type
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Dow, Michelle; Pyke, Rachel M; Tsui, Brian Y et al. (2018) Integrative genomic analysis of mouse and human hepatocellular carcinoma. Proc Natl Acad Sci U S A 115:E9879-E9888
Que, Xuchu; Hung, Ming-Yow; Yeang, Calvin et al. (2018) Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice. Nature 558:301-306
Murzin, Vyacheslav L; Woods, Kaley; Moiseenko, Vitali et al. (2018) 4? plan optimization for cortical-sparing brain radiotherapy. Radiother Oncol 127:128-135
Norton, Jeffrey A; Kim, Teresa; Kim, Joseph et al. (2018) SSAT State-of-the-Art Conference: Current Surgical Management of Gastric Tumors. J Gastrointest Surg 22:32-42
Ikeda, Sadakatsu; Tsigelny, Igor F; Skjevik, Åge A et al. (2018) Next-Generation Sequencing of Circulating Tumor DNA Reveals Frequent Alterations in Advanced Hepatocellular Carcinoma. Oncologist 23:586-593
Buckley, Alexandra R; Ideker, Trey; Carter, Hannah et al. (2018) Exome-wide analysis of bi-allelic alterations identifies a Lynch phenotype in The Cancer Genome Atlas. Genome Med 10:69
Parish, Austin J; Nguyen, Vi; Goodman, Aaron M et al. (2018) GNAS, GNAQ, and GNA11 alterations in patients with diverse cancers. Cancer 124:4080-4089
Xu, Selene; Thompson, Wesley; Ancoli-Israel, Sonia et al. (2018) Cognition, quality-of-life, and symptom clusters in breast cancer: Using Bayesian networks to elucidate complex relationships. Psychooncology 27:802-809
Tao, Li; Schwab, Richard B; San Miguel, Yazmin et al. (2018) Breast Cancer Mortality in Older and Younger Breast Cancer Patients in California. Cancer Epidemiol Biomarkers Prev :
Sagredo, Eduardo A; Blanco, Alejandro; Sagredo, Alfredo I et al. (2018) ADAR1-mediated RNA-editing of 3'UTRs in breast cancer. Biol Res 51:36

Showing the most recent 10 out of 862 publications